Healx is a fast growing Cambridge, UK startup combining computational methods and drug discovery expertise to identify existing drugs that may treat rare diseases, enabling treatments to be found at a fraction of the time and cost of traditional drug discovery. There are over 7,000 rare diseases that affect an estimated 350 million people worldwide, most of which lack effective treatment. We have recently announced raising $56M Series B investment that will allow us to take more drug programs into clinical trials and grow our team. Our goal is having a patient impact at scale through technology.